Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.40 |
| ▸ | APP | P05067 | 5/20 | 0.38 |
| ▸ | RNASEH1 | O60930 | 1/20 | 0.37 |
| ▸ | TYR | P14679 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | MDM4 | O15151 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6999429 | 0.86 | KDM4E (0.53) | KDM4ELMNAMAPK1FTOAPP | |
| SCHEMBL22449893 | 0.80 | KDM4E (0.47) | KDM4ELMNAMAPK1FTOAPP | |
| SCHEMBL13150868 | 0.77 | KDM4E (0.38) | KDM4ELMNAMAPK1FTOHPGD | |
| SCHEMBL13180808 | 0.77 | KDM4E (0.42) | KDM4ELMNAMAPK1FTOHPGD | |
| SCHEMBL8143882 | 0.75 | KDM4E (0.42) | KDM4ELMNAMAPK1FTOAPP | |
| SCHEMBL6196974 | 0.73 | KDM4E (0.49) | KDM4ELMNAMAPK1FTOAPP | |
| SCHEMBL7136835 | 0.73 | KDM4E (0.44) | KDM4ELMNAFTOAPP | |
| SCHEMBL30262402 | 0.73 | — | — | |
| SCHEMBL6195700 | 0.72 | LMNA (0.43) | KDM4ELMNAMAPK1FTOAPP | |
| Maltol SCHEMBL4815 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250161182-A1 | ANTIMICROBIAL COMPOSITIONS | BIO-ACTIVES SYNERGIO LTD (IL) | 2025-05-22 | — | — | US | claimed |
| EP-4469037-A1 | ANTIMICROBIAL COMPOSITIONS | Bio-Actives Synergio Ltd (IL) | 2024-12-04 | — | — | EP | claimed |
| CN-118660702-A | Antimicrobial compositions | 生物活性协同有限公司 | 2024-09-17 | — | — | CN | claimed |
| CN-116687962-A | Composition for preventing or treating diabetes and application thereof | 青岛大学 | 2023-09-05 | — | — | CN | claimed |
| WO-2023144808-A1 | ANTIMICROBIAL COMPOSITIONS | BIO-ACTIVES SYNERGIO LTD (IL) | 2023-08-03 | — | — | WO | claimed |
| CN-106667992-B | Use of coniferyl aldehyde or coniferyl aldehyde and vanadium compound composition for preventing and treating neurodegenerative diseases | 北京大学 | 2020-04-03 | — | — | CN | claimed |
| EP-3290044-A1 | ANTIBACTERIAL COMPOSITION, COMPRISING A PLANT EXTRACT, METHOD FOR OBTAINING THE EXTRACT, PHARMACEUTICAL COMPOSITION AND USE | SjF Hanse Scientific UG (DE) | 2018-03-07 | — | — | EP | claimed |
| EP-0473764-A1 | METAL COMPLEXES | Hider, Robert Charles (GB) | 1992-03-11 | — | — | EP | claimed |
| WO-1991014664-A1 | METAL COMPLEXES | HIDER ROBERT CHARLES (GB) | 1991-10-03 | — | — | WO | claimed |
| EP-0263138-B1 | IMPROVEMENTS IN OR RELATING TO THE TREATMENT OF SICKLE CELL DISEASE | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1991-06-12 | — | — | EP | claimed |
| US-4894455-A | Pharmaceutically active zinc complexes | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1990-01-16 | — | — | US | claimed |
| US-4866052-A | TREATING BLOOD WITH ZINC HYDROXY YRONE COMPLETE ENHANCES OXYGE N BINDING AFFINITY | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1989-09-12 | — | — | US | claimed |
| EP-0271529-A1 | PHARMACEUTICAL COMPOSITIONS | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1988-06-22 | — | — | EP | claimed |
| EP-0263138-A1 | IMPROVEMENTS IN OR RELATING TO THE TREATMENT OF SICKLE CELL DISEASE. | NAT RES DEV (GB) | 1988-04-13 | — | — | EP | claimed |
| WO-1987007893-A1 | PHARMACEUTICAL COMPOSITIONS | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1987-12-30 | — | — | WO | claimed |
| WO-1987005509-A1 | IMPROVEMENTS IN OR RELATING TO THE TREATMENT OF SICKLE CELL DISEASE | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1987-09-24 | — | — | WO | claimed |
| CN-116687962-B | Composition for preventing or treating diabetes and application thereof | QINGDAO UNIVERSITY (CN) | 2026-05-26 | — | — | CN | disclosed |
| US-20250161182-A1 | ANTIMICROBIAL COMPOSITIONS | BIO-ACTIVES SYNERGIO LTD (IL) | 2025-05-22 | — | — | US | disclosed |
| US-4608367-A | γ-Pyrone phosphoric ester derivatives and insecticidal and miticidal compositions thereof | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1986-08-26 | — | — | US | disclosed |
| US-4059595-A | Process for preparing 3-oxy-4H-pyran-4-one derivatives | OTSUKA KAGAKU YAKUHIN KABUSHIKI KAISHI (JA) | 1977-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250161182-A1 | ANTIMICROBIAL COMPOSITIONS | NOD2, PYCARD, CLPP | KDM4E 4332/4885LMNA 2204/4885MAPK1 4031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.